The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype

被引：5

作者：

Liberopoulos, E ^{[1
]}

Pavlidis, N ^{[1
]}

Elisaf, M ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece

来源：

CLINICAL BIOCHEMISTRY | 2001年 / 34卷 / 02期

关键词：

D O I：

10.1016/S0009-9120(01)00197-7

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：161 / 161

页数：1

共 9 条

[1] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].

DAVIGNON, J ;

GREGG, RE ;

SING, CF .

ARTERIOSCLEROSIS, 1988, 8 (01) :1-21

[2] LONG-TERM EFFECTS OF TAMOXIFEN ON BLOOD LIPID VALUES IN BREAST-CANCER [J].

DEWAR, JA ;

HOROBIN, JM ;

PREECE, PE ;

TAVENDALE, R ;

TUNSTALLPEDOE, H ;

WOOD, RAB .

BRITISH MEDICAL JOURNAL, 1992, 305 (6847) :225-226

[3]

Elisaf M, 1996, ANTICANCER RES, V16, P2725

[4] Apolipoprotein E polymorphism in men and women from a Spanish population:: allele frequencies and influence on plasma lipids and apolipoproteins [J].

Gómez-Coronado, D ;

Alvarez, JJ ;

Entrala, A ;

Olmos, JM ;

Herrera, E ;

Lasunción, MA .

ATHEROSCLEROSIS, 1999, 147 (01) :167-176

[5]

LOPEZMIRANDA J, 1994, J LIPID RES, V35, P1965

[6] Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy [J].

Mastroianni, A ;

Bellati, C ;

Facchetti, G ;

Oldani, S ;

Franzini, C ;

Berrino, F .

CLINICAL BIOCHEMISTRY, 2000, 33 (06) :513-516

[7] EFFECT OF APOLIPOPROTEIN-E AND A-IV PHENOTYPES ON THE LOW-DENSITY-LIPOPROTEIN RESPONSE TO HMG COA REDUCTASE INHIBITOR THERAPY [J].

ORDOVAS, JM ;

LOPEZMIRANDA, J ;

PEREZJIMENEZ, F ;

RODRIGUEZ, C ;

PARK, JS ;

COLE, T ;

SCHAEFER, EJ .

ATHEROSCLEROSIS, 1995, 113 (02) :157-166

[8]

SEISHIMA M, 1991, J LIPID RES, V32, P941

[9]

STAELS B, 1989, J LIPID RES, V30, P1137

← 1 →